2138-00
Open for Enrollment
Phase: II
This study is being done to find out if photodynamic therapy (treatment with a red light and a drug called photofrin) works as well for patients who have biomarkers (a presence of abnormalities in molecules of cells that may or may not help predict cancer) present in their Barrett's esophagus as compared to patients who do not have biomarkers present. Participants should have a history of Barrett's esophagus.
Barrett's esophagus
Barrett's esophagus with low-grade or high-grade dysplasia
18
1 or 2 day screening visit, if assigned to treatment, there will be a 3-day visit within the next 6 weeks than a return for 1 day visits every 3 months for 1 year
Lori Lutzke at 507-255-7495 or barretts@mayo.edu
Last updated: 10/25/2007
Legal restrictions and terms of use applicable to this site
Use of this site signifies your agreement to the terms of use
Copyright © 2009 Mayo Foundation for Medical Education and Research.